Incidence of heart failure in relation to QRS duration during antihypertensive therapy: The LIFE study Academic Article uri icon

Overview

MeSH Major

  • Antihypertensive Agents
  • Atenolol
  • Electrocardiography
  • Heart Failure
  • Losartan

abstract

  • Persistence or development of a prolonged QRS during antihypertensive therapy is associated with an increased likelihood of new-onset heart failure, independent of blood pressure lowering, treatment modality and regression of electrocardiographic LVH in patients with essential hypertension. These findings suggest that serial assessment of QRS over time can be used to track the risk of heart failure in hypertensive patients.

publication date

  • November 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/HJH.0b013e328330b66b

PubMed ID

  • 19834342

Additional Document Info

start page

  • 2271

end page

  • 7

volume

  • 27

number

  • 11